Interleukin-22-Producing Natural Killer Cells and Lymphoid Tissue Inducer-like Cells in Mucosal Immunity

Immunity

Volumn 31, Issue 1, 2009, Pages 15-23

  Colonna, Marco ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 23; PROTEIN ROR GAMMA T; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; CYTOKINE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL FUNCTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENTERITIS; HOST RESISTANCE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; INTESTINE FLORA; INTESTINE LYMPHATIC TISSUE; LYMPHOID TISSUE INDUCER LIKE CELL; MUCOSAL IMMUNITY; NATURAL KILLER CELL; NONHUMAN; PLACENTA; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; ANIMAL; IMMUNOLOGY; INNATE IMMUNITY; INTESTINE MUCOSA; METABOLISM;

ANIMALS; CELL DIFFERENTIATION; CYTOKINES; HUMANS; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; INTERLEUKIN-23; INTERLEUKINS; INTESTINAL MUCOSA; KILLER CELLS, NATURAL;

EID: 68249137286     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2009.06.008     Document Type: Review

References (83)

1. Adachi S., Yoshida H., Kataoka H., and Nishikawa S. Three distinctive steps in Peyer's patch formation of murine embryo. Int. Immunol. 9 (1997) 507-514
2. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., and Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278 (2003) 1910-1914
3. Ahern P.P., Izcue A., Maloy K.J., and Powrie F. The interleukin-23 axis in intestinal inflammation. Immunol. Rev. 226 (2008) 147-159
4. Aujla S.J., Chan Y.R., Zheng M., Fei M., Askew D.J., Pociask D.A., Reinhart T.A., McAllister F., Edeal J., Gaus K., et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14 (2008) 275-281
5. Aujla S.J., and Kolls J.K. IL-22: a critical mediator in mucosal host defense. J. Mol. Med. 87 (2009) 451-454
6. Bettelli E., Korn T., Oukka M., and Kuchroo V.K. Induction and effector functions of T(H)17 cells. Nature 453 (2008) 1051-1057
7. Biron C.A. Interferons alpha and beta as immune regulators-a new look. Immunity 14 (2001) 661-664
8. Boniface K., Bernard F.X., Garcia M., Gurney A.L., Lecron J.C., and Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol. 174 (2005) 3695-3702
9. Bouskra D., Brezillon C., Berard M., Werts C., Varona R., Boneca I.G., and Eberl G. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456 (2008) 507-510
10. Brand S., Beigel F., Olszak T., Zitzmann K., Eichhorst S.T., Otte J.M., Diepolder H., Marquardt A., Jagla W., Popp A., et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am. J. Physiol. Gastrointest. Liver Physiol. 290 (2006) G827-G838
11. Bryceson Y.T., and Long E.O. Line of attack: NK cell specificity and integration of signals. Curr. Opin. Immunol. 20 (2008) 344-352
12. Caligiuri M.A. Human natural killer cells. Blood 112 (2008) 461-469
13. Cella M., Fuchs A., Vermi W., Facchetti F., Otero K., Lennerz J.K., Doherty J.M., Mills J.C., and Colonna M. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457 (2009) 722-725
14. Chen Z., Laurence A., and O'Shea J.J. Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. Semin. Immunol. 19 (2007) 400-408
15. Chinen H., Matsuoka K., Sato T., Kamada N., Okamoto S., Hisamatsu T., Kobayashi T., Hasegawa H., Sugita A., Kinjo F., et al. Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells. Gastroenterology 133 (2007) 559-573
16. Chung Y., Yang X., Chang S.H., Ma L., Tian Q., and Dong C. Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes. Cell Res. 16 (2006) 902-907
17. Croy B.A., He H., Esadeg S., Wei Q., McCartney D., Zhang J., Borzychowski A., Ashkar A.A., Black G.P., Evans S.S., et al. Uterine natural killer cells: insights into their cellular and molecular biology from mouse modelling. Reproduction 126 (2003) 149-160
18. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421 (2003) 744-748
19. Cupedo T., Crellin N.K., Papazian N., Rombouts E.J., Weijer K., Grogan J.L., Fibbe W.E., Cornelissen J.J., and Spits H. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat. Immunol. 10 (2009) 66-74
20. Di Santo J.P. Functionally distinct NK-cell subsets: developmental origins and biological implications. Eur. J. Immunol. 38 (2008) 2948-2951
21. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., Steinhart A.H., Abraham C., Regueiro M., Griffiths A., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314 (2006) 1461-1463
22. Dumoutier L., Van Roost E., Colau D., and Renauld J.C. Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc. Natl. Acad. Sci. USA 97 (2000) 10144-10149
23. Eberl G., and Littman D.R. The role of the nuclear hormone receptor RORgammat in the development of lymph nodes and Peyer's patches. Immunol. Rev. 195 (2003) 81-90
24. Freud A.G., and Caligiuri M.A. Human natural killer cell development. Immunol. Rev. 214 (2006) 56-72
25. Gasser S., and Raulet D. The DNA damage response, immunity and cancer. Semin. Cancer Biol. 16 (2006) 344-347
26. Gerosa F., Baldani-Guerra B., Lyakh L.A., Batoni G., Esin S., Winkler-Pickett R.T., Consolaro M.R., De Marchi M., Giachino D., Robbiano A., et al. Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J. Exp. Med. 205 (2008) 1447-1461
27. Hayakawa Y., Huntington N.D., Nutt S.L., and Smyth M.J. Functional subsets of mouse natural killer cells. Immunol. Rev. 214 (2006) 47-55
28. Hor S., Pirzer H., Dumoutier L., Bauer F., Wittmann S., Sticht H., Renauld J.C., de Waal Malefyt R., and Fickenscher H. The T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chains. J. Biol. Chem. 279 (2004) 33343-33351
29. Hughes T., Becknell B., McClory S., Briercheck E., Freud A.G., Zhang X., Mao H., Nuovo G., Yu J., and Caligiuri M.A. Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22. Blood 113 (2009) 4008-4010
30. Ivanov I.I., Zhou L., and Littman D.R. Transcriptional regulation of Th17 cell differentiation. Semin. Immunol. 19 (2007) 409-417
31. Karre K. NK cells, MHC class I molecules and the missing self. Scand. J. Immunol. 55 (2002) 221-228
32. Kimura A., Naka T., Nohara K., Fujii-Kuriyama Y., and Kishimoto T. Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc. Natl. Acad. Sci. USA 105 (2008) 9721-9726
33. Kotenko S.V. The family of IL-10-related cytokines and their receptors: related, but to what extent?. Cytokine Growth Factor Rev. 13 (2002) 223-240
34. Kullberg M.C., Jankovic D., Feng C.G., Hue S., Gorelick P.L., McKenzie B.S., Cua D.J., Powrie F., Cheever A.W., Maloy K.J., and Sher A. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 203 (2006) 2485-2494
35. Lanier L.L. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9 (2008) 495-502
36. Lee Y.K., Turner H., Maynard C.L., Oliver J.R., Chen D., Elson C.O., and Weaver C.T. Late developmental plasticity in the T helper 17 lineage. Immunity 30 (2009) 92-107
37. LeibundGut-Landmann S., Gross O., Robinson M.J., Osorio F., Slack E.C., Tsoni S.V., Schweighoffer E., Tybulewicz V., Brown G.D., Ruland J., and Reis e Sousa C. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8 (2007) 630-638
38. Liang S.C., Tan X.Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., and Fouser L.A. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203 (2006) 2271-2279
39. Lockhart E., Green A.M., and Flynn J.L. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 177 (2006) 4662-4669
40. Luci C., Reynders A., Ivanov I.I., Cognet C., Chiche L., Chasson L., Hardwigsen J., Anguiano E., Banchereau J., Chaussabel D., et al. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat. Immunol. 10 (2009) 75-82
41. Ma H.L., Liang S., Li J., Napierata L., Brown T., Benoit S., Senices M., Gill D., Dunussi-Joannopoulos K., Collins M., et al. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J. Clin. Invest. 118 (2008) 597-607
42. Manaster I., and Mandelboim O. The unique properties of human NK cells in the uterine mucosa. Placenta 29 Suppl A (2008) S60-S66
43. McGeachy M.J., and Cua D.J. The link between IL-23 and Th17 cell-mediated immune pathologies. Semin. Immunol. 19 (2007) 372-376
44. Mebius R.E., Rennert P., and Weissman I.L. Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7 (1997) 493-504
45. Michel M.L., Keller A.C., Paget C., Fujio M., Trottein F., Savage P.B., Wong C.H., Schneider E., Dy M., and Leite-de-Moraes M.C. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J. Exp. Med. 204 (2007) 995-1001
46. Michel M.L., Mendes-da-Cruz D., Keller A.C., Lochner M., Schneider E., Dy M., Eberl G., and Leite-de-Moraes M.C. Critical role of ROR-gammat in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc. Natl. Acad. Sci. USA 105 (2008) 19845-19850
47. Munz C. Non-cytotoxic protection by human NK cells in mucosal secondary lymphoid tissues. Eur. J. Immunol. 38 (2008) 2946-2948
48. Murphy C.A., Langrish C.L., Chen Y., Blumenschein W., McClanahan T., Kastelein R.A., Sedgwick J.D., and Cua D.J. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198 (2003) 1951-1957
49. Nagalakshmi M.L., Murphy E., McClanahan T., and de Waal Malefyt R. Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization. Int. Immunopharmacol. 4 (2004) 577-592
50. Nagalakshmi M.L., Rascle A., Zurawski S., Menon S., and de Waal Malefyt R. Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. Int. Immunopharmacol. 4 (2004) 679-691
51. Pabst O., Herbrand H., Worbs T., Friedrichsen M., Yan S., Hoffmann M.W., Korner H., Bernhardt G., Pabst R., and Forster R. Cryptopatches and isolated lymphoid follicles: dynamic lymphoid tissues dispensable for the generation of intraepithelial lymphocytes. Eur. J. Immunol. 35 (2005) 98-107
52. Quinton L.J., Jones M.R., Robson B.E., Simms B.T., Whitsett J.A., and Mizgerd J.P. Alveolar epithelial STAT3, IL-6 family cytokines, and host defense during Escherichia coli pneumonia. Am. J. Respir. Cell Mol. Biol. 38 (2008) 699-706
53. Rachitskaya A.V., Hansen A.M., Horai R., Li Z., Villasmil R., Luger D., Nussenblatt R.B., and Caspi R.R. Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J. Immunol. 180 (2008) 5167-5171
54. Sanos S.L., Bui V.L., Mortha A., Oberle K., Heners C., Johner C., and Diefenbach A. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat. Immunol. 10 (2009) 83-91
55. Satoh-Takayama N., Vosshenrich C.A., Lesjean-Pottier S., Sawa S., Lochner M., Rattis F., Mention J.J., Thiam K., Cerf-Bensussan N., Mandelboim O., et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29 (2008) 958-970
56. Scalzo A.A., and Yokoyama W.M. Cmv1 and natural killer cell responses to murine cytomegalovirus infection. Curr. Top. Microbiol. Immunol. 321 (2008) 101-122
57. Scandella E., Bolinger B., Lattmann E., Miller S., Favre S., Littman D.R., Finke D., Luther S.A., Junt T., and Ludewig B. Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. Nat. Immunol. 9 (2008) 667-675
58. Shibata K., Yamada H., Hara H., Kishihara K., and Yoshikai Y. Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol. 178 (2007) 4466-4472
59. Sugimoto K., Ogawa A., Mizoguchi E., Shimomura Y., Andoh A., Bhan A.K., Blumberg R.S., Xavier R.J., and Mizoguchi A. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118 (2008) 534-544
60. Sun Z., Unutmaz D., Zou Y.R., Sunshine M.J., Pierani A., Brenner-Morton S., Mebius R.E., and Littman D.R. Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science 288 (2000) 2369-2373
61. Takatori H., Kanno Y., Watford W.T., Tato C.M., Weiss G., Ivanov I.I., Littman D.R., and O'Shea J.J. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 206 (2009) 35-41
62. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3 (2003) 133-146
63. Umemura M., Yahagi A., Hamada S., Begum M.D., Watanabe H., Kawakami K., Suda T., Sudo K., Nakae S., Iwakura Y., and Matsuzaki G. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J. Immunol. 178 (2007) 3786-3796
64. Veldhoen M., Hirota K., Christensen J., O'Garra A., and Stockinger B. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J. Exp. Med. 206 (2009) 43-49
65. Veldhoen M., Hirota K., Westendorf A.M., Buer J., Dumoutier L., Renauld J.C., and Stockinger B. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453 (2008) 106-109
66. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., and Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 (2006) 179-189
67. Veldhoen M., Hocking R.J., Flavell R.A., and Stockinger B. Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat. Immunol. 7 (2006) 1151-1156
68. Vondenhoff M.F., Kraal G., and Mebius R.E. Lymphoid organogenesis in brief. Eur. J. Immunol. 37 Suppl 1 (2007) S46-S52
69. Weaver C.T., and Murphy K.M. T-cell subsets: the more the merrier. Curr. Biol. 17 (2007) R61-R63
70. Williams I.R. CCR6 and CCL20: partners in intestinal immunity and lymphorganogenesis. Ann. N Y Acad. Sci. 1072 (2006) 52-61
71. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., Basham B., Smith K., Chen T., Morel F., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8 (2007) 950-957
72. Wolk K., Haugen H.S., Xu W., Witte E., Waggie K., Anderson M., Vom Baur E., Witte K., Warszawska K., Philipp S., et al. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J. Mol. Med. 87 (2009) 523-536
73. Wolk K., Kunz S., Witte E., Friedrich M., Asadullah K., and Sabat R. IL-22 increases the innate immunity of tissues. Immunity 21 (2004) 241-254
74. Wolk K., and Sabat R. Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev. 17 (2006) 367-380
75. Wolk K., Witte E., Hoffmann U., Doecke W.D., Endesfelder S., Asadullah K., Sterry W., Volk H.D., Wittig B.M., and Sabat R. IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease. J. Immunol. 178 (2007) 5973-5981
76. Wolk K., Witte E., Wallace E., Docke W.D., Kunz S., Asadullah K., Volk H.D., Sterry W., and Sabat R. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 36 (2006) 1309-1323
77. Yokota Y., Mansouri A., Mori S., Sugawara S., Adachi S., Nishikawa S., and Gruss P. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397 (1999) 702-706
78. Yoshida H., Honda K., Shinkura R., Adachi S., Nishikawa S., Maki K., Ikuta K., and Nishikawa S.I. IL-7 receptor alpha+ CD3(-) cells in the embryonic intestine induces the organizing center of Peyer's patches. Int. Immunol. 11 (1999) 643-655
79. Zenewicz L.A., and Flavell R.A. IL-22 and inflammation: leukin' through a glass onion. Eur. J. Immunol. 38 (2008) 3265-3268
80. Zenewicz L.A., Yancopoulos G.D., Valenzuela D.M., Murphy A.J., Karow M., and Flavell R.A. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27 (2007) 647-659
81. Zenewicz L.A., Yancopoulos G.D., Valenzuela D.M., Murphy A.J., Stevens S., and Flavell R.A. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29 (2008) 947-957
82. Zheng Y., Danilenko D.M., Valdez P., Kasman I., Eastham-Anderson J., Wu J., and Ouyang W. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445 (2007) 648-651
83. Zheng Y., Valdez P.A., Danilenko D.M., Hu Y., Sa S.M., Gong Q., Abbas A.R., Modrusan Z., Ghilardi N., de Sauvage F.J., and Ouyang W. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14 (2008) 282-289